Keywords: Abbott Labs, Cost-cutting, Job losses, Solvay integration

Abbott Labs plans cost-cutting, 3,000 job losses as a result of Solvay integration

Article | 22 September 2010

Print This

US health care giant Abbott Laboratories (NYSE: ABT) has announced a restructuring plan related to its $7.1 billion acquisition of Belgium ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in